16May
Apexigen Investor Day
Apexigen, a clinical-stage company focused on developing innovative antibody-based therapeutics for...
17May
KOL Webinar on VYNE’s BET Inhibitor Platform
The VYNE Therapeutics KOL Webinar will feature a presentation from Gerald V....
18May
Captor Therapeutics R&D Day
The Power of Targeted Protein Degradation (TPD) and How It Could...
19May
Virtual KOL Event on TScan’s TCR-T Therapies
TScan will provide a summary of the Company’s ASGCT posters and...
19May
MindMed KOL Webinar on Substance Use Disorders & Withdrawal Management
The webinar will feature presentations from Key Opinion Leaders (KOLs) Kelly E....
23May
KOL Event on Quotient’s MosaiQ™ Solution
The webinar will feature a presentation from Key Opinion Leader (KOL) Christophe...
25May
KOL Breakfast on Valneva’s Chikungunya Vaccine Candidate (pre-BLA stage)
Wednesday, May 25, 2022 Registration & Breakfast: 7:00 AM ET /...
26May
Arrowhead Pharmaceuticals Pulmonary R&D Day
Join us for the Arrowhead Pulmonary R&D Day, featuring presentations from...
2Jun
KOL Event on Tenax’s TNX-201 (imatinib): A Potential Treatment for Pulmonary Arterial Hypertension
The webinar will feature presentations from Key Opinion Leaders (KOL’s) Anna Hemnes,...
2Jun
Aptose Biosciences KOL Data Call on HM43239 and Luxeptinib: Potential Treatment Candidates for AML
The data call will feature Key Opinion Leaders (KOL’s) Brian Druker, M.D....